HeartBEATS from Lifelong Learning™

Addressing social determinants of health (SDOH) requires a multifaceted approach involving various sectors and stakeholders. There are population groups and underlying medical conditions that can increase the risk of mild to moderate COVID-19 infection, progressing to a severe outcome. The speakers will discuss these aspects and provide strategies for change.  CE and ABIM MOC credits available:  h...

In this episode, learn from leading experts about managing preeclampsia with and without severe features. The panel will define the pathophysiology and potential for multi-organ system impact with preeclampsia; discussion to include postpartum care recommendations.  Claim CE and MOC credit here: https://bit.ly/ManagePreeclampsia

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders of pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders of pregnancy; discussion to include recommended medications as well as postpartum care. Claim CE and MOC credit here  https://bit.ly/ChronicHTN

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings. Dr. Ridker also highlights the importance of primary prevention str...

In this episode, Dr. Brittany Weber discusses the role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular disease. She explores the connection between inflammation and atherosclerosis and how immune system activation contributes to atherosclerosis development, the importance of endothelial damage and pro-inflammatory cytokines, and the impact of systemic inflammatory diseases on c...

In this episode, Dr. Amir Rezvan hosts a panel discussion with distinguished colleagues Dr. Paul Ridker, Dr. Brendan Everett, Dr. Michael Garshick, and Dr. Kaitlin Voigts Key. The panel explores what high-sensitivity CRP (hs-CRP) is and its normal levels, the role of hsCRP in diagnosing and treating atherosclerotic disease, and how inflammation and hyperlipidemia contribute to cardiovascular event...

In this episode, Dr. Brendan Everett discusses how lifestyle changes can reduce low-grade systemic inflammation. He explores the impact of weight loss on high-sensitivity CRP (hs-CRP)levels, the benefits of different diet types, and the role of exercise and smoking cessation in managing inflammation. Watch now to learn how lifestyle interventions can play a crucial role in reducing inflammation an...

In this episode, Dr. Michael Garshick discusses the role of pharmacologic interventions in managing inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular (CV) disease. Key topics include the involvement of inflammation in atherosclerosis and atherothrombosis, traditional targets such as dyslipidemia, hypertension, and antiplatelet therapy, and the complexity of targeting inflammation an...

In this episode, Dr. Paul Ridker explores the crucial role of inflammation and high-sensitivity CRP (hs-CRP) in cardiovascular health. He discusses the importance of measuring hsCRP and addresses common misconceptions about the variability of this biomarker. Tune in to gain a deeper understanding of how hsCRP can be a powerful tool in predicting and managing cardiovascular health.

In this episode, hear from leading experts as they define the major health issues in hypertensive disorders associated with pregnancy. Learn how to outline the appropriate work-up to diagnose hypertensive disorders in pregnancy; discussion to include postpartum care recommendations. Claim CE and MOC credits:   https://bit.ly/IntroHTDP

This episode will focus on the challenges of living with Long COVID, including barriers to being diagnosed with the condition and ongoing issues with finding effective therapies. Patient perspectives will be highlighted. CE and ABIM MOC credits available: https://bit.ly/4eQCC2g

This vodcast explores the role of telehealth in hypertension management, covering its definition and the key components for a successful virtual visit, such as self-measured blood pressure and treatment protocols. Experts outline the essential resources required to implement a telehealth service and address important equity considerations to ensure inclusive and effective care for all patients. 

Episode 3 of the Unmet Needs in HTN Vodcast Series.   In this vodcast episode, we dissect evidence-based approaches to hypertension management, from lifestyle interventions to single-pill combination therapies. We explore implementation strategies to boost adherence to both lifestyle modifications and medication therapy, and review treatment algorithms for optimal medication use and the identifica...

It is essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness. In this episode, Dr. Jeffrey Hsu talks with Dr. Biykem Bozkurt about the cardiovascular effects of COVID-19, including myocarditis, as well as a review of the risks of myocarditis with COVID-19 vaccination. CE and ABIM MOC credits...

Episode 2 in the Unmet Needs in Hypertension Vodcast Series Discussing the strategies of lifestyle management of blood pressure. In this vodcast, watch experts detail the importance of diet, exercise, and other behavioral modifications in lowering and maintaining blood pressure.    ACCME, ABIM MOC, and ANCC CE credits available.

Episode 1 of the Unmet Needs in HTN Vodcast Series. This vodcast delves into the essentials of home blood pressure monitoring (HBPM). Experts discuss why HBPM is crucial for managing hypertension effectively and discover the various benefits it offers to patients. Join us on discussion of educating patients on selecting the right monitoring device, preparing for accurate readings, and integrating...

Conversation around how a cardiologist or non-endocrinologist starts GLP-1 RAs. We will explore dose escalation, concerns about hypoglycemia, managing other glucose lowering agents, how to deal with adverse effects and other important topics. Claim CE Credit at https://bit.ly/3xqdZJg  

Conversation around the barriers to GLP-1 RAS. Dr. Trudy Gaillard and Dr. Monica Peek discuss adverse effects, cost, strategies when taking with other medications, social determinants of health, and educational support. Claim CE and MOC Credit at   https://bit.ly/4bmIxu0

Conversation around patient selection and GLP-1 RAs. The speakers will explore the effects of GLP-1 RAs and SGLT-2 inhibitors on clinical outcomes and CVD risk factors.  Claim CE Credit at https://bit.ly/4aSgdzz  

It has been essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness.  Dr. Jeff Hsu talks with Dr. Carrie Harvey about the cardiovascular risks with COVID-19, diagnostic tools, clinical manifestations, short and long-term cardiovascular outcomes after recovery from the acute infection. Recommen...

In this episode, a panel of experts discuss existing VTE treatment options, algorithms, corresponding safety and efficacy profiles along with safety and efficacy data, and protocols to address treatment pathways. Claim CE and MOC Credit at  https://bit.ly/VTEIII

COVID-19 care is now mostly provided outside of hospital settings. Early diagnosis and therapeutic intervention for those who are at increased risk of progression to severe COVID-19 may improve outcomes. Dr. Jeff Hsu talks with Dr. Mary Brennan about the symptoms associated with the different stages of SARS-CoV-2 and choosing the appropriate outpatient therapeutic treatment.   CE and ABIM MOC cred...

C onversation about the approved GLP-1 RAs to manage type 2 diabetes mellitus (T2DM). Forms of administration, contextualizing the many benefits and the risks, and indications will be discussed. Claim CE Credit at https://bit.ly/49Ultlu

Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity.  Claim CE Credit at https://bit.ly/3OkYJm9

Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP...